RxDoctor Payments Data

Junior Pittack

Psychiatry · Hialeah, FLNPI 1023053931

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 461 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,109 and has fallen 62.4% since, to $1,169 in 2025. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,057in general payments, 2019–2025

Across 461 payments — averaging $23.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Otsuka America Pharmaceutical, Inc.$2K
  • Lundbeck LLC$1K
  • Sunovion Pharmaceuticals Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$544
  • plus $3K from 17 others
$1,647,090in research payments, 2019–2025

Across 467 payments — averaging $3526.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alkermes, Inc.$1.3M
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$353K

What the payments were for

  • Food & beverage$10,89999%
  • Education$1581%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,057 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Olanzapine104$2,616
Atomoxetine Hcl27$2,366
Alprazolam231$1,771
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine51$1,660
Aripiprazole25$1,655
Quetiapine Fumarate105$1,569
Chlorpromazine Hcl14$1,455
Trazodone Hcl81$1,353
Risperidone67$1,230
Oxcarbazepine26$1,107
Mirtazapine101$913
Ziprasidone Hcl21$877
Clonazepam112$818
Gabapentin82$801
AmantadineAmantadine Hcl13$800

Paid to pharmacies, not to this prescriber.

Other psychiatry in Hialeah

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →